Clinical Trials on Hypofyse neoplasmer

Total 107523 results

Dr. Kaweh Mansouri

Enrolling by invitation

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register

Glaucoma, Angle-Closure | Surgery | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma; Drugs | Glaucoma, Pigmentary | Glaucoma Secondary | Glaucoma Open-Angle | Glaucoma Congenital | Glaucoma Capsulare

Switzerland
University Hospitals Cleveland Medical Center
National Institute of Neurological Disorders and Stroke (NINDS); The Cleveland... and other collaborators

Completed

Mitochondrial Biomarkers in Huntington's Disease

Huntington Disease

United States
EIP Pharma Inc
Voisin Consulting, Inc.

Terminated

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

Huntington Disease

United Kingdom
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)

Huntington's Disease

Germany, Canada, United Kingdom
Hospital Universitario de Burgos
La Caixa Foundation; Universidad Isabel I

Completed

Energy Balance in Huntington's Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM) (BEHD-EM)

Huntington Disease

Spain
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (PRECISION-HD1)

Huntington's Disease

Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Institut Bergonié
Bristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai Pharmaceutical

Completed

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (PHRC2003)

Digestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic Disease

France
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Heinrich-Heine University, Duesseldorf
Medtronic; The George Institute; KKS Netzwerk; CHDI Foundation, Inc.; Egyptian Society...

Completed

Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) (HD-DBS)

Huntington Disease

Austria, Germany, France, Switzerland
Hoffmann-La Roche

Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Huntington's Disease

United Kingdom, United States, Germany, Canada
University Rehabilitation Institute, Republic of...

Completed

Functional Exercise in Virtual Environment for Persons With Multiple Sclerosis or Parkinson's Disease (MEFA)

Multiple Sclerosis | Parkinson Disease

Slovenia
Verrica Pharmaceuticals Inc.
BioClinica, Inc.; Paidion Research, Inc.; Instat Consulting, Inc.

Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts (CARE-1)

Skin Diseases | Sexually Transmitted Diseases, Viral | Sexually Transmitted Diseases | Skin Diseases, Infectious | Warts | Papillomavirus Infections | Skin Diseases, Viral | Condylomata Acuminata

United States
Institut National de la Santé Et de la Recherche...

Completed

Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study (COGIT)

Tourette Syndrome

France
Institut National de la Santé Et de la Recherche...
Ultragenyx Pharmaceutical Inc

Completed

A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (TRIHEP3)

Huntington Disease

France, Netherlands
Chang Gung Memorial Hospital

Completed

The Assessment of the Diagnosis and Prognosis of Patients With Alzheimer Disease or Parkinson Disease With Cognitive Impairment by Using Diffusion MRI

Parkinson Disease | Alzheimer Disease

Taiwan
Prilenia
Huntington Study Group; European Huntington's Disease Network

Completed

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Huntington's Disease

United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Second Affiliated Hospital of Soochow University

Completed

Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease

Parkinson Disease

China
The Third Xiangya Hospital of Central South University

Active, not recruiting

Domestic Surgical Robot Clinical Study

Gastric Cancer | Rectal Cancer | Appendicitis | Colon Cancer | Cholecystolithiasis | Gastric Bypass | Sleeve Gastrectomy | Gastric Ulcer With Perforation But Without Obstruction

China
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Tourette's Disorder (TD)

United States, Canada, Hungary
Association de Recherche Bibliographique pour les...
Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse Grace

Completed

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography (EYE-SEP)

Healthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary Progressive

Monaco
Jody Corey-Bloom, MD, PhD
Forest Laboratories

Completed

Study of Memantine to Treat Huntington's Disease

Huntington's Disease

United States
Hannover Medical School
German Research Foundation

Completed

CANNAbinoids in the Treatment of TICS (CANNA-TICS) (CANNA-TICS)

Tourette Syndrome | Tic Disorders

Germany
Assiut University

Completed

The Effect of High Frequency rTMS on Advancing Parkinson's Disease With Dysphagia

Advanced Parkinson's With Dysphagia

Egypt
Corestem, Inc.

Completed

Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy

Multiple System Atrophy

Korea, Republic of
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod (LEGATO-HD)

Huntington's Disease

United States, Canada, Czechia, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, United Kingdom
CHDI Foundation, Inc.

Unknown

Development of Assessments for Later Stage HD (LSA)

Huntington Disease

United States, United Kingdom
Seoul National University Hospital
SMG-SNU Boramae Medical Center

Completed

Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior Disorder

Parkinson Disease | REM Sleep Behavior Disorder

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Huntington Disease

Korea, Republic of
Danish Headache Center
Novartis; Amgen

Completed

Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache

Post-Concussion Syndrome | Mild Traumatic Brain Injury | Post-Traumatic Headache

Denmark
Lancaster University
Manchester University NHS Foundation Trust

Completed

A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease

Huntington Disease

United Kingdom
National Cancer Institute (NCI)
Multicenter Hemophilia Cohort Study

Completed

The Second Multicenter Hemophilia Cohort Study

Hepatocellular Carcinoma | Non-Hodgkin Lymphoma | Liver Decompensation

United States, Germany, Italy, Brazil, Canada, France, Greece, Sweden
Radboud University Medical Center
Universitaire Ziekenhuizen KU Leuven

Completed

Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections (PIRAÑA)

Acute Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome

Belgium, Netherlands
Bausch Health Americas, Inc.

Withdrawn

A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome (TBZ-MR)

Tourette's Syndrome
Cardiff University
CHDI Foundation, Inc.

Unknown

PHysical Activity and Exercise Outcomes in Huntington's Disease (PACE-HD)

Huntington Disease

Spain, Germany, United States
CHDI Foundation, Inc.
Dr. Glenn T. Stebbins (Rush University Medical Center ); Dr. Nancy LaPelle

Completed

FuRST 2.0 Cognitive Pre-testing - Round 2

Huntington Disease

United States, Canada
University Hospital Inselspital, Berne
Boston Scientific Corporation

Terminated

Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM (LATESTIM)

Parkinson Disease | Movement Disorders | Neurodegenerative Disorders | Central Nervous System Disease | Basal Ganglia Disease

Switzerland
CHDI Foundation, Inc.

Completed

Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers (LONGPDE10)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
Proteon Therapeutics

Completed

A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

Chronic Kidney Disease

United States, Canada
Teachers College, Columbia University

Completed

Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD

Huntington's Disease

United States
Cardiff University
Health and Care Research Wales; Jacque and Gloria Gossweiler Foundation

Completed

Exploring Computerised Cognitive Training for People With Huntington's Disease (CogTrainHD)

Huntington's Disease

United Kingdom
University Health Network, Toronto

Unknown

Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration

Parkinson's Disease | Frontotemporal Lobar Degeneration | Alzheimer's Disease

Canada
University Hospital, Bordeaux

Completed

Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy (CogAMS)

Multiple System Atrophy

France
BioSensics
University of Rochester

Unknown

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease

Huntington Disease

United States
Ipsen

Terminated

Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients

Huntington's Disease

Germany
Omeros Corporation

Terminated

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Huntington's Disease

United States
Amsterdam UMC, location VUmc
Centre for Human Drug Research, Netherlands

Terminated

Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease (VESPA)

Parkinson's Disease

Netherlands
Johns Hopkins University
National Institute of Nursing Research (NINR); University of Chicago

Completed

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Pancreatic Cancer | Amyotrophic Lateral Sclerosis | GI Cancer

United States
Wang . Jiun-Jie
National Health Research Institutes, Taiwan

Completed

Accelerated Diffusion MRI for Diagnosis of Hungtington Disease

Huntington Disease

Taiwan
New York Medical College

Completed

Effect of Tetrabenazine on Stroop Interference in HD

Huntington Disease

United States

Clinical Trials on Hypofyse neoplasmer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations